The product licences and responsibility for the sales, marketing and distribution of Efcortesol (hydrocortisone sodium phosphate) injection 100mg/ml (5 x 1ml, 10 x 5ml) and Prednesol (prednisolone sodium phosphate) tablets (100 x 5mg), have been transferred from Glaxo Wellcome to Sovereign Medical, a division of Waymade Healthcare Plc. From November 1, all orders and inquiries should be addressed to Sovereign Medical, Sovereign House, Miles Gray Road , Basildon, Essex, SS14 3FR (tel 01268 531111).